Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Bantscheff

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Science (New York, N.Y.)|March 21, 2020
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammationOmer Gilan, Inmaculada Rioja, Kathy Knezevic, et al.
Nature Chemical Biology|October 6, 2015
New IDH1 mutant inhibitors for treatment of acute myeloid leukemiaUjunwa C Okoye-Okafor, Boris Bartholdy, Jessy Cartier, et al.
Nature|May 31, 2019
Author Correction: Design of amidobenzimidazole STING receptor agonists with systemic activityJoshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, et al.
Nature|November 9, 2018
Design of amidobenzimidazole STING receptor agonists with systemic activityJoshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, et al.
Cancer Discovery|April 8, 2024
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer CellsGabriele Picco, Yanhua Rao, Angham Al Saedi, et al.
The Journal of Clinical Investigation|December 12, 2017
Drug-perturbation-based stratification of blood cancerSascha Dietrich, Małgorzata Oleś, Junyan Lu, et al.
Journal of Medicinal Chemistry|August 13, 2024
Discovery of Potent STT3A/B Inhibitors and Assessment of Their Multipathogen Antiviral Potential and SafetyJoseph E Pero, Elizabeth A Mueller, Ashley M Adams, et al.
Science Translational Medicine|April 28, 2017
Antimalarial efficacy of MMV390048, an inhibitor of <i>Plasmodium</i> phosphatidylinositol 4-kinaseTanya Paquet, Claire Le Manach, Diego González Cabrera, et al.
Nature Cancer|November 18, 2021
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B Pappalardi, Kathryn Keenan, Mark Cockerill, et al.
Nature Biotechnology|February 9, 2008
Human Proteinpedia enables sharing of human protein dataSuresh Mathivanan, Mukhtar Ahmed, Natalie G Ahn, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Science (New York, N.Y.)|March 21, 2020
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammationOmer Gilan, Inmaculada Rioja, Kathy Knezevic, et al.
Nature Chemical Biology|October 6, 2015
New IDH1 mutant inhibitors for treatment of acute myeloid leukemiaUjunwa C Okoye-Okafor, Boris Bartholdy, Jessy Cartier, et al.
Nature|May 31, 2019
Author Correction: Design of amidobenzimidazole STING receptor agonists with systemic activityJoshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, et al.
Nature|November 9, 2018
Design of amidobenzimidazole STING receptor agonists with systemic activityJoshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, et al.
Cancer Discovery|April 8, 2024
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer CellsGabriele Picco, Yanhua Rao, Angham Al Saedi, et al.
The Journal of Clinical Investigation|December 12, 2017
Drug-perturbation-based stratification of blood cancerSascha Dietrich, Małgorzata Oleś, Junyan Lu, et al.
Journal of Medicinal Chemistry|August 13, 2024
Discovery of Potent STT3A/B Inhibitors and Assessment of Their Multipathogen Antiviral Potential and SafetyJoseph E Pero, Elizabeth A Mueller, Ashley M Adams, et al.
Science Translational Medicine|April 28, 2017
Antimalarial efficacy of MMV390048, an inhibitor of <i>Plasmodium</i> phosphatidylinositol 4-kinaseTanya Paquet, Claire Le Manach, Diego González Cabrera, et al.
Nature Cancer|November 18, 2021
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B Pappalardi, Kathryn Keenan, Mark Cockerill, et al.
Nature Biotechnology|February 9, 2008
Human Proteinpedia enables sharing of human protein dataSuresh Mathivanan, Mukhtar Ahmed, Natalie G Ahn, et al.
Pageof 12